East Orange, NJNCT05588843Now EnrollingIRB Ready

Ulcerative Colitis Clinical Trial in East Orange, NJ

Access cutting-edge ulcerative colitis treatment through this clinical trial at a research site in East Orange. Study-provided care at no cost to qualified participants.

Sponsored by Sanofi

Quick Self-Assessment

See if you qualify for this East Orange location

Preparing your pre-screening questions...

Expert Care in East Orange

Access ulcerative colitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ulcerative colitis treatment provided free

Apply for This East Orange Location

Check if you qualify for this ulcerative colitis clinical trial in East Orange, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to East Orange

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit East Orange site if eligible
  4. 4Begin participation

About This Ulcerative Colitis Study in East Orange

This is a randomized, double-blind, placebo controlled, dose-ranging Phase 2 study. The primary objective is to evaluate the efficacy and safety of SAR443122 compared to placebo in participants with moderate to severe UC. Dose selection for further clinical development will be based on the multiple efficacy, safety and PK parameters. The study consists of 4 parallel arms (3 dose groups of SAR443122 vs placebo) to assess the efficacy and safety of SAR443122 in participants with moderate to sever

Sponsor: Sanofi

Who Can Participate

Inclusion Criteria

Participants who have clinical evidence of active Ulcerative Colitis \[UC\] for ≥3 months before screening as confirmed by endoscopy during the screening period.
Participants must have a minimum disease extent of 15 centimeters from the anal verge.
Participants are inadequate or non-responders, have shown loss of response, or are intolerant to at least 1 of following approved treatments: amino-salicylate, corticosteroids, immunosuppressants or biologics other than natalizumab (Tysabri®) or small molecules.
Participants on corticosteroids must be on a stable dose ≥2 weeks prior to screening and during screening period.
Participants on methotrexate, azathioprine or 6- mercaptopurine must be on treatment for at least 8 weeks prior to screening; and on a stable dose ≥4 weeks prior to screening and during screening period.
Participants on oral 5-aminosalicylates, mesalamine or sulfasalazine must be on a stable dose for ≥4 weeks prior to screening and during

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in East Orange?

Yes, this clinical trial (NCT05588843) has an active research site in East Orange, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ulcerative Colitis Treatment Options in East Orange, NJ

If you're searching for ulcerative colitis treatment options in East Orange, NJ, this clinical trial (NCT05588843) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our East Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ulcerative colitis clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in East Orange, NJ

See all rheumatoid arthritis clinical trials recruiting in East Orange — not just this study.

Browse Rheumatoid Arthritis Trials in East Orange →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsUlcerative Colitis TrialsInflammatory Bowel Disease TrialsAll Conditions →

Ready to Join in East Orange?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · East Orange, NJ